Buprenorphine - NDC Database (Page 7)
69238-1202 Apr 20, 2020
Buprenorphine 5 ug/H Transdermal Patch, Extended Release by Amneal Pharmaceuticals Ny LLC
Buprenorphine 5 ug/H Transdermal Patch, Extended Release by Amneal Pharmaceuticals Ny LLC
69238-1203 Apr 20, 2020
Buprenorphine 10 ug/H Transdermal Patch, Extended Release by Amneal Pharmaceuticals Ny LLC
Buprenorphine 10 ug/H Transdermal Patch, Extended Release by Amneal Pharmaceuticals Ny LLC
69238-1204 Apr 20, 2020
Buprenorphine 15 ug/H Transdermal Patch, Extended Release by Amneal Pharmaceuticals Ny LLC
Buprenorphine 15 ug/H Transdermal Patch, Extended Release by Amneal Pharmaceuticals Ny LLC
69238-1205 Apr 20, 2020
Buprenorphine 20 ug/H Transdermal Patch, Extended Release by Amneal Pharmaceuticals Ny LLC
Buprenorphine 20 ug/H Transdermal Patch, Extended Release by Amneal Pharmaceuticals Ny LLC
69238-1505 Apr 20, 2020
Buprenorphine 7.5 ug/H Transdermal Patch, Extended Release by Amneal Pharmaceuticals Ny LLC
Buprenorphine 7.5 ug/H Transdermal Patch, Extended Release by Amneal Pharmaceuticals Ny LLC
70069-027 Feb 11, 2025
Buprenorphine Hydrochloride .324 mg/ml Intramuscular; Intravenous Injection by Somerset Therapeutics, LLC
Buprenorphine Hydrochloride .324 mg/ml Intramuscular; Intravenous Injection by Somerset Therapeutics, LLC
70518-0652 Jul 31, 2017
Buprenorphine Hydrochloride Sublingual Sublingual 2 mg Sublingual Tablet by Remedyrepack Inc.
Buprenorphine Hydrochloride Sublingual Sublingual 2 mg Sublingual Tablet by Remedyrepack Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.